发布求助
文献互助 智能选刊 最新文献

European journal of anaesthesiology. Supplement最新文献

筛选
英文 中文
Remifentanil: when and how to use it. 瑞芬太尼:何时以及如何使用。
European journal of anaesthesiology. Supplement Pub Date : 1997-05-01 DOI: 10.1097/00003643-199705001-00008
F Servin
{"title":"Remifentanil: when and how to use it.","authors":"F Servin","doi":"10.1097/00003643-199705001-00008","DOIUrl":"https://doi.org/10.1097/00003643-199705001-00008","url":null,"abstract":"<p><p>Remifentanil is a new potent mu-agonist with a unique pharmacokinetic profile due to a rapid metabolism by non-specific tissue esterases. As a consequence, remifentanil pharmacokinetics are not modified by severe renal or hepatic dysfunction. During general anaesthesia, any dosage of remifentanil may be used without undue lengthening of emergence times. In cardiac surgery, remifentanil combines the requirement for intra-operative control of stress responses and rapid recovery. The rapid termination of remifentanil action warrants modifications of the current practice concerning early postoperative pain control. Remifentanil may be used as a sedative during monitored analgesia, or as a postoperative analgesic in spontaneously breathing patients, provided bolus doses are avoided. Remifentanil may increase patients' safety by eliminating the risk of delayed respiratory depression, but its correct use requires major changes in our prescribing habits.</p>","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":"15 ","pages":"41-4"},"PeriodicalIF":0.0,"publicationDate":"1997-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20148384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
Update in intravenous anaesthesia. Proceedings of the 7th International Symposium on Intravenous Anaesthesia. Lausanne, Switzerland, 2-3 May 1997. 静脉麻醉的最新情况。第七届国际静脉麻醉研讨会论文集。1997年5月2日至3日，瑞士洛桑。
European journal of anaesthesiology. Supplement Pub Date : 1997-05-01
{"title":"Update in intravenous anaesthesia. Proceedings of the 7th International Symposium on Intravenous Anaesthesia. Lausanne, Switzerland, 2-3 May 1997.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":"15 ","pages":"1-60"},"PeriodicalIF":0.0,"publicationDate":"1997-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20148425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The psychological and psychiatric consequences of the ICU stay. ICU住院的心理和精神后果。
European journal of anaesthesiology. Supplement Pub Date : 1997-05-01 DOI: 10.1097/00003643-199705001-00009
R S Blacher
{"title":"The psychological and psychiatric consequences of the ICU stay.","authors":"R S Blacher","doi":"10.1097/00003643-199705001-00009","DOIUrl":"https://doi.org/10.1097/00003643-199705001-00009","url":null,"abstract":"<p><p>From the patient's point of view, the Intensive Care Unit is both a frightening place and a safe haven. Psychologically, what we see most commonly are regression, delirium and paranola. Regression requires no treatment; delirium is treatable not only medically but psychologically as well; paranoia is best treated by prevention.</p>","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":"15 ","pages":"45-7"},"PeriodicalIF":0.0,"publicationDate":"1997-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20148385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Intravenous anaesthetics: some cellular sites of action. 静脉麻醉:作用于某些细胞部位。
European journal of anaesthesiology. Supplement Pub Date : 1997-05-01 DOI: 10.1097/00003643-199705001-00002
M Dzoljic, A W Gelb
{"title":"Intravenous anaesthetics: some cellular sites of action.","authors":"M Dzoljic,&nbsp;A W Gelb","doi":"10.1097/00003643-199705001-00002","DOIUrl":"https://doi.org/10.1097/00003643-199705001-00002","url":null,"abstract":"<p><p>Intravenous anaesthetics have diverse effects on neurones within the central nervous system. Only those that occur at clinical concentrations are likely to be relevant. The dominant effect of many agents is the potentiation of the inhibitory neurotransmitter gamma amino butyric acid (GABA) by various mechanisms while inhibiting the effects of excitatory transmitters seems to be less dominant, except for ketamine.</p>","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":"15 ","pages":"3-7"},"PeriodicalIF":0.0,"publicationDate":"1997-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20148426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Propofol: pro- or anticonvulsant? 异丙酚:促惊厥药还是抗惊厥药?
European journal of anaesthesiology. Supplement Pub Date : 1997-05-01 DOI: 10.1097/00003643-199705001-00004
A Borgeat
{"title":"Propofol: pro- or anticonvulsant?","authors":"A Borgeat","doi":"10.1097/00003643-199705001-00004","DOIUrl":"https://doi.org/10.1097/00003643-199705001-00004","url":null,"abstract":"<p><p>The pro- or anticonvulsant properties of propofol remain a matter of controversy. Although numerous case reports describe the appearance of abnormal movements, posturing and seizure-like activity related to the use of propofol, systematic studies in both humans and animals strongly suggest that it possesses antiepileptic properties. Propofol consistently reduces the seizure duration during electroconvulsive therapy, its use has been successful in controlling refractory status epilepticus and in animals it offers a strong protection against lignocaine- or pentylene-tetrazol-induced epilepsy. The beneficial effects of propofol may be related to its uniform depressant action on the central nervous system, to a potentialization of GABA-mediated pre- and postsynaptic inhibition, and by decreasing the release of excitatory transmitters, glutamate and aspartate.</p>","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":"15 ","pages":"17-20"},"PeriodicalIF":0.0,"publicationDate":"1997-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20148428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 38
Monitoring depth of anaesthesia. 监测麻醉深度。
European journal of anaesthesiology. Supplement Pub Date : 1997-05-01 DOI: 10.1097/00003643-199705001-00005
G Schneider, P S Sebel
{"title":"Monitoring depth of anaesthesia.","authors":"G Schneider,&nbsp;P S Sebel","doi":"10.1097/00003643-199705001-00005","DOIUrl":"https://doi.org/10.1097/00003643-199705001-00005","url":null,"abstract":"<p><p>In clinical practice, indirect and non-specific signs are used for monitoring anaesthetic adequacy. These include haemodynamic, respiratory, muscular and autonomic signs. These measures do not indicate adequacy of anaesthesia in a reliable manner. Many attempts have been made to find a more accurate monitor. Direct monitoring of anaesthetic effect should be possible by EEG measurement. EEG information can be reduced, condensed and simplified, leading to single numbers (spectral edge frequency and median frequency). These methods appear insufficient for assessing anaesthetic adequacy. The bispectral index, derived from bispectral analysis of the EEG, is a very promising tool for measuring adequacy of anaesthesia. An alternative approach is to monitor evoked potentials. Middle latency auditory evoked potentials may be helpful in assessing anaesthetic adequacy. Both techniques need further validation.</p>","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":"15 ","pages":"21-8"},"PeriodicalIF":0.0,"publicationDate":"1997-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20148429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 66
Pain treatment in the ICU: intravenous, regional or both? ICU疼痛治疗:静脉注射、局部治疗还是两者兼用?
European journal of anaesthesiology. Supplement Pub Date : 1997-05-01 DOI: 10.1097/00003643-199705001-00010
W Kröll, W F List
{"title":"Pain treatment in the ICU: intravenous, regional or both?","authors":"W Kröll,&nbsp;W F List","doi":"10.1097/00003643-199705001-00010","DOIUrl":"https://doi.org/10.1097/00003643-199705001-00010","url":null,"abstract":"<p><p>Adequate treatment of pain in ICU patients should be an integral part of ICU management, as inadequately treated pain leads to a series of complications that may counteract the success of ICU treatment. For continuous intravenous use we recommend sufentanil in a dose of 0.75-1.0 microgram kg-1 h-1 in mechanically ventilated patients and in a dose of 0.25-0.35 microgram kg-1 h-1 in intubated and spontaneously breathing patients. On-demand analgesia, administered via the intravenous or epidural route, may be an alternative to a relatively fixed continuous infusion of an analgesic drug, and in some ICU patients the transdermal use of opioids can be an alternative to continuous intravenous drug application or PCA. Increased sizes of the patch (25, 50, 75, 100 cm2) provide sustained transdermal rates of approximately 25, 50, 75 and 100 micrograms h-1 of fentanyl over a period up to about 72 hours. Patients with trauma to the thorax, pelvic fracture, or after major surgical interventions will be better managed by regional application of analgesic drugs alone or in combination with a systemic analgesic drug infusion. To achieve the best results it is necessary to be well informed and trained in the method, to know the advantages and disadvantages, the correct and modified dosages of the drugs used, and the indications and contraindications.</p>","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":"15 ","pages":"49-52"},"PeriodicalIF":0.0,"publicationDate":"1997-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20148386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
How to manage drug interactions. 如何管理药物相互作用。
European journal of anaesthesiology. Supplement Pub Date : 1997-05-01 DOI: 10.1097/00003643-199705001-00007
P S Glass, S Howell, T J Gan, B Ginsberg
{"title":"How to manage drug interactions.","authors":"P S Glass,&nbsp;S Howell,&nbsp;T J Gan,&nbsp;B Ginsberg","doi":"10.1097/00003643-199705001-00007","DOIUrl":"https://doi.org/10.1097/00003643-199705001-00007","url":null,"abstract":"<p><p>Multiple drugs are used to provide anaesthesia. On average, four to six drugs are used during anaesthesia and, therefore, drug interactions are common. These interactions are primarily either pharmacokinetic or pharmacodynamic. Due to the relatively short duration of drug administration for anaesthesia, pharmacokinetic drug interactions resulting from alterations in drug metabolism do not generally produce clinically significant effects. Pharmacodynamic-drug interactions between anaesthetic drugs, however, are potentially serious. This may reflect that anaesthesia is not a single entity, but a process provided by a combination of drugs; i.e. loss of consciousness, analgesia and neuromuscular blockade. An understanding of each drug's pharmacokinetics, pharmacodynamics and drug interactions will allow clinicians to administer drugs to provide a more optimal anaesthetic.</p>","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":"15 ","pages":"33-9"},"PeriodicalIF":0.0,"publicationDate":"1997-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20148431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
High-dose desmopressin in bleeding disorders. 大剂量去氨加压素在出血性疾病中的应用。
European journal of anaesthesiology. Supplement Pub Date : 1997-03-01 DOI: 10.1097/00003643-199703001-00001
J T Douglas, J Shaw
{"title":"High-dose desmopressin in bleeding disorders.","authors":"J T Douglas,&nbsp;J Shaw","doi":"10.1097/00003643-199703001-00001","DOIUrl":"https://doi.org/10.1097/00003643-199703001-00001","url":null,"abstract":"","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":"14 ","pages":"v-vi"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20040359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders. 去氨加压素治疗先天性和获得性出血性疾病的临床经验综述。
European journal of anaesthesiology. Supplement Pub Date : 1997-03-01 DOI: 10.1097/00003643-199703001-00003
M Cattaneo
{"title":"Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders.","authors":"M Cattaneo","doi":"10.1097/00003643-199703001-00003","DOIUrl":"https://doi.org/10.1097/00003643-199703001-00003","url":null,"abstract":"This paper discusses clinical experience of the use of desmopressin in patients with either congenital or acquired bleeding disorders. The bleeding disorders reviewed herein are haemophilia A, von Willebrand's disease and platelet function disorders (congenital bleeding disorders); uraemia, liver cirrhosis and drug-induced bleeding (acquired bleeding disorders).","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":"14 ","pages":"10-4; discussion 14-8"},"PeriodicalIF":0.0,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20040361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信